IZRL vs. SBIO ETF Comparison

Comparison of ARK Israel Innovative Technology ETF (IZRL) to ALPS Medical Breakthroughs ETF (SBIO)
IZRL

ARK Israel Innovative Technology ETF

IZRL Description

The ARK Israel Innovative Technology ETF (IZRL) seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index, which is designed to track the price movements of exchange-listed Israeli companies whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology. The Index includes equity securities and depositary receipts of exchange listed companies that are incorporated and/or domiciled in Israel (‘‘Israeli Companies’’) and are included in one of the following economic sectors as defined by FactSet Research Systems: (i) health technology, (ii) communications, (iii) technology services, (iv) electronic technology, (v) consumer services, or (vi) producer manufacturing.

Grade (RS Rating)

Last Trade

$20.34

Average Daily Volume

13,195

Number of Holdings *

24

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$38.26

Average Daily Volume

6,572

Number of Holdings *

83

* may have additional holdings in another (foreign) market
Performance
Period IZRL SBIO
30 Days 4.63% 1.91%
60 Days 1.45% 2.27%
90 Days 3.78% 7.65%
12 Months 24.33% 52.91%
1 Overlapping Holdings
Symbol Grade Weight in IZRL Weight in SBIO Overlap
URGN F 1.7% 0.35% 0.35%
IZRL Overweight 23 Positions Relative to SBIO
Symbol Grade Weight
CLBT A 2.77%
SMWB C 2.6%
RDWR C 2.46%
TEVA A 2.36%
CHKP F 2.34%
ITRN C 2.29%
MNDY A 2.27%
FVRR A 2.21%
CYBR C 2.18%
WKME A 2.14%
CGNT F 2.1%
MGIC C 2.07%
WIX B 2.06%
PLTK A 1.94%
SPNS B 1.93%
AUDC F 1.92%
NICE C 1.9%
INMD C 1.85%
MDWD A 1.75%
RSKD F 1.63%
FROG C 1.57%
NNOX F 1.57%
SSYS F 1.45%
IZRL Underweight 82 Positions Relative to SBIO
Symbol Grade Weight
RNA C -3.38%
KRYS C -3.33%
CORT B -3.2%
CRNX B -3.04%
ACLX B -3.02%
IMVT F -2.93%
ALKS F -2.88%
DNLI C -2.39%
MRUS C -2.38%
FOLD B -2.27%
ZLAB B -2.11%
PTCT B -2.05%
XENE C -2.03%
EWTX B -2.03%
VRNA A -1.83%
PTGX B -1.77%
CGON F -1.67%
AGIO B -1.65%
IDYA F -1.61%
ACAD F -1.57%
GERN C -1.55%
VERA A -1.5%
KROS A -1.41%
VCEL D -1.35%
LBPH A -1.34%
AKRO A -1.3%
MIRM B -1.25%
GLPG F -1.25%
ARVN C -1.22%
CLDX F -1.21%
MNKD A -1.14%
BCRX A -1.1%
SNDX F -1.07%
IMCR F -1.06%
RCUS F -1.04%
NTLA F -1.03%
TARS A -0.97%
VRDN B -0.93%
SPRY B -0.92%
IRON D -0.9%
KURA F -0.89%
COGT B -0.89%
XNCR A -0.87%
DAWN A -0.85%
PHVS A -0.77%
APLT A -0.71%
AUPH A -0.65%
ANAB F -0.59%
PRTA F -0.58%
LQDA C -0.58%
PLRX A -0.56%
ETNB D -0.54%
REPL B -0.53%
ERAS C -0.48%
ANNX B -0.47%
OLMA F -0.46%
MLYS B -0.44%
YMAB A -0.43%
IRWD F -0.4%
CELC D -0.4%
ALLO D -0.38%
SVRA D -0.37%
FLGT C -0.37%
ARCT F -0.35%
AURA B -0.34%
FULC F -0.34%
ALT D -0.32%
ALEC D -0.3%
CMPS F -0.29%
AVXL A -0.29%
TBPH C -0.28%
FDMT F -0.27%
GHRS D -0.25%
ALDX D -0.21%
ACIU F -0.2%
INZY F -0.19%
STRO D -0.19%
ITOS F -0.19%
ENTA D -0.17%
VNDA D -0.17%
ZNTL D -0.15%
HLVX C -0.06%
Compare ETFs